ES2125898T3 - Glicolipidos sulfatados que contienen un resto de galactosa-3-0-sulfato, y captadores especificos para los mismos, para uso en profilaxis o terapia de prediabetes, diabetes y/o complicaciones asociadas en un individuo. - Google Patents

Glicolipidos sulfatados que contienen un resto de galactosa-3-0-sulfato, y captadores especificos para los mismos, para uso en profilaxis o terapia de prediabetes, diabetes y/o complicaciones asociadas en un individuo.

Info

Publication number
ES2125898T3
ES2125898T3 ES92910435T ES92910435T ES2125898T3 ES 2125898 T3 ES2125898 T3 ES 2125898T3 ES 92910435 T ES92910435 T ES 92910435T ES 92910435 T ES92910435 T ES 92910435T ES 2125898 T3 ES2125898 T3 ES 2125898T3
Authority
ES
Spain
Prior art keywords
sulphate
prediabetes
diabetes
individual
galactose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92910435T
Other languages
English (en)
Inventor
Karsten Buschard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A+ Science AB
Original Assignee
A+ Science Invest AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A+ Science Invest AB filed Critical A+ Science Invest AB
Application granted granted Critical
Publication of ES2125898T3 publication Critical patent/ES2125898T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

CIERTOS GLICOSIDAS Y RECEPTORES ESPECIFICOS DE ESTOS PARA SU USO EN LA PROFILAXIS O TERAPIA DE PREDIABETES, DIABETES Y/O COMPLICACIONES ASOCIADA A SU USO RESPECTIVAMENTE PARA LA DETECCION DE ANTICUERPOS DE CELULAS ISLOTES EN UN INDIVIDUO Y DE CELULAS ISLOTES DE LANGERHAN EN PREPARACIONES PANCREATICAS.
ES92910435T 1991-05-07 1992-05-07 Glicolipidos sulfatados que contienen un resto de galactosa-3-0-sulfato, y captadores especificos para los mismos, para uso en profilaxis o terapia de prediabetes, diabetes y/o complicaciones asociadas en un individuo. Expired - Lifetime ES2125898T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91846A DK84691D0 (da) 1991-05-07 1991-05-07 Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater

Publications (1)

Publication Number Publication Date
ES2125898T3 true ES2125898T3 (es) 1999-03-16

Family

ID=8098211

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92910435T Expired - Lifetime ES2125898T3 (es) 1991-05-07 1992-05-07 Glicolipidos sulfatados que contienen un resto de galactosa-3-0-sulfato, y captadores especificos para los mismos, para uso en profilaxis o terapia de prediabetes, diabetes y/o complicaciones asociadas en un individuo.

Country Status (9)

Country Link
US (1) US5827828A (es)
EP (1) EP0584175B1 (es)
JP (1) JP3222465B2 (es)
AT (1) ATE175203T1 (es)
AU (1) AU1788892A (es)
DE (1) DE69228061T2 (es)
DK (2) DK84691D0 (es)
ES (1) ES2125898T3 (es)
WO (1) WO1992019633A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580858A (en) * 1991-06-10 1996-12-03 Alberta Research Council Immunosuppressive and tolerogenic modified Lewisx compounds
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5663151A (en) * 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
US5686426A (en) 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
SE9601817D0 (sv) 1996-05-13 1996-05-13 Karsten Buschard Novel glycolipid complexex and their uses
CA2286482C (en) * 1997-04-10 2008-08-05 Kirin Beer Kabushiki Kaisha Nkt cell-activating agents containing .alpha.-glycosylceramides
JP2001527046A (ja) * 1997-12-30 2001-12-25 エイプラス サイエンス インベスト アーベー ガラクトシルセラミド、グルコシルセラミド、ラクトシルセラミド、並びに前糖尿病、糖尿病および／または関連合併症の予防もしくは治療に使用するためのその特定キャッチャー
SE0000258D0 (sv) 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
CN100439383C (zh) 2001-08-16 2008-12-03 阿斯比奥制药株式会社 糖脂及其作为有效成分的用于自体免疫疾病的药物
JP5564672B2 (ja) * 2006-06-30 2014-07-30 ザ スクリプス リサーチ インスティテュート アジュバント及びその使用方法
FR2926972B1 (fr) * 2008-02-05 2011-03-11 Technologia Appareil de diagnostic precoce du syndrome du canal carpien et procede et dispositif d'acquisition de l'information relative a la sensibilite cutanee du doigt du patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288706A (en) * 1987-12-25 1994-02-22 Mitsui Toatsu Chemicals, Incorporated Medicament for prevention and remedy of diseases of the pancreas and others

Also Published As

Publication number Publication date
EP0584175A1 (en) 1994-03-02
US5827828A (en) 1998-10-27
WO1992019633A1 (en) 1992-11-12
DE69228061D1 (de) 1999-02-11
JPH06506943A (ja) 1994-08-04
ATE175203T1 (de) 1999-01-15
AU1788892A (en) 1992-12-21
DE69228061T2 (de) 1999-05-27
DK84691D0 (da) 1991-05-07
DK0584175T3 (da) 1999-08-30
JP3222465B2 (ja) 2001-10-29
EP0584175B1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
ES2125898T3 (es) Glicolipidos sulfatados que contienen un resto de galactosa-3-0-sulfato, y captadores especificos para los mismos, para uso en profilaxis o terapia de prediabetes, diabetes y/o complicaciones asociadas en un individuo.
DK120184D0 (da) Materiale og middel til detektering af naervaerelsen af et peroxidativt aktivt stof i en testproeve,samt fremstilling og anvendelse deraf
BR8301376A (pt) Valvula para uso em uma coluna de teste de poco
NO161407C (no) Fremgangsmaate og anordning til aa verifisere at innehaveren av et kort som er utstyrt med maskinlesbare markeringer,er berettiget til aa anvende kortet.
BR7608467A (pt) Processo e dispositivo para teste de gravidez,bem como processo para detecao de condicoes fisiologicas associadas a presenca de gonadotropinas na urina ou no soro
ES497804A0 (es) Procedimiento para detectar sustancias peroxidativamente activas en una muestra.
ES496753A0 (es) Procedimiento de obtencion de una composicion para detectar la presencia de un azucar en una muestra de ensayo
ES495905A0 (es) Perfeccionamientos en bastidores para el almacenamiento de conjuntos combustibles nucleares
BR7702481A (pt) Processo,dispositivo e estojo para detectar o inicio da ovulacao na mulher
BR8002734A (pt) Oligomero, processo para a sua preparacao, seu uso, composicao de concentrado e processo para extinguir incendio em liquido hidrofobo
PT88689A (pt) Dispositivo para determinacao da concentracao de compostos quimicos desidrogenaveis/hidrogenaveis por enzimas em solucoes aquosas
DK31391A (da) Pentacycliske triterpenoidforbindelser som topoisomeraseinhibitorer eller celledifferentieringsfremkaldere
ES8103379A1 (es) Un sistema microcroma tografico perfeccionado para controlarla ingestion de medicamentos por parte de un paciente.
JPS52126136A (en) Disfigurement detecting system using figure outline information
Hathaway Subclinical effects of trinitrotoluene: A review of epidemiology studies.
JPS52125623A (en) Quantitative determination of antigenic substances and reagent kit for the same
PT1171578E (pt) Composicao farmaceutica compreendendo as celulas nkt activadas pelo pim e sua utilizacao em terapia
JPS5264593A (en) Neutron detector for out-core instrumentation
SE7705987L (sv) Referensmaterial for att uppretthalla anjonkoncentrationer vid analytiska kemiska tester, samt framstellning och anvendning derav
JPS5373190A (en) Indicating apparatus of cup arrangement for serum sampling
YU et al. Asymmetric stress and failure analysis
PREFACED et al. RECORD HOUSES OF 1982
FR2378506A1 (fr) Matieres absorbantes et leur procede de fabrication
ES2066713B1 (es) Metodo para la deteccion de los sistemas abo y rh en hematies.
孙骊 Nouns of Measurement or Unit and Subject-Verb Concord

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 584175

Country of ref document: ES